MedPath

AIN SHAMS UNIVERSITY

AIN SHAMS UNIVERSITY logo
🇪🇬Egypt
Ownership
Private
Established
1950-01-01
Employees
10K
Market Cap
-
Website
http://net.shams.edu.eg

Paracetamol Versus Ibuprofen for PDA Closure

Phase 4
Conditions
Patent Ductus Arteriosus
Interventions
First Posted Date
2017-08-29
Last Posted Date
2017-08-29
Lead Sponsor
Ain Shams University
Target Recruit Count
30
Registration Number
NCT03265782

Effect of Right Lateral Position on Ventilated Preterm Neonates

Not Applicable
Completed
Conditions
Gastro Esophageal Reflux
Interventions
Behavioral: positioning
First Posted Date
2017-08-23
Last Posted Date
2017-08-23
Lead Sponsor
Ain Shams University
Target Recruit Count
60
Registration Number
NCT03258528

Effect of Alpha Lipoic Acid on Uterine Scar Healing After Cesarean Section

Phase 2
Completed
Conditions
Cesarean Section; Dehiscence
Cesarean Scar Niche
Interventions
Drug: alpha lipoic acid drug (thioctic acid acid)
Drug: Placebo Oral Tablet
First Posted Date
2017-08-22
Last Posted Date
2018-03-08
Lead Sponsor
Ain Shams University
Target Recruit Count
102
Registration Number
NCT03257514
Locations
🇪🇬

Ain Shams University Maternity Hospital, Cairo, Abbassia, Egypt

A Comparative Study Between Dissociative Treatment and Binocular Interactive Treatment in Amblyopia

Not Applicable
Completed
Conditions
Amblyopia
Interventions
Device: dichoptic treatment
Device: eye patch
First Posted Date
2017-08-21
Last Posted Date
2022-11-29
Lead Sponsor
Ain Shams University
Target Recruit Count
80
Registration Number
NCT03255707
Locations
🇪🇬

Ain Shams University Hospitals (Demerdash), Cairo, Egypt

Comparison of Lipophilic Versus Hydrophilic Statins on Patients With Heart Failure

Phase 4
Completed
Conditions
Heart Failure
Interventions
Drug: Rosuvastatin
Drug: Atorvastatin
Other: guideline directed therapy
First Posted Date
2017-08-21
Last Posted Date
2020-01-09
Lead Sponsor
Ain Shams University
Target Recruit Count
85
Registration Number
NCT03255044
Locations
🇪🇬

Ain Shams University Hospital Cardiology Rehab Unit, Cairo, Egypt

Ascorbic Acid Versus Diode Laser in the Treatment of Gingival Hyperpigmentation

Phase 4
Completed
Conditions
Gingival Hyperpigmentaion
Interventions
Drug: Ascorbic Acid 500 MG
Device: diode laser
First Posted Date
2017-08-17
Last Posted Date
2017-08-22
Lead Sponsor
Ain Shams University
Target Recruit Count
10
Registration Number
NCT03252418

Duloxetine and Dexamethasone for Improving Postoperative Pain

Phase 4
Completed
Conditions
Post Operative Pain Control
Interventions
Drug: Dulox capsule (60mg)
Drug: combined Dulox capsule (60 mg) orally and Dex 0.1mg/kg diluted in 100 ml 0.9% NS IVI
Drug: a placebo capsule identical to Dulox capsule and 100 ml 0.9% NS IVI over 15 min, as a placebo for dexamethasone
First Posted Date
2017-08-15
Last Posted Date
2017-08-15
Lead Sponsor
Ain Shams University
Target Recruit Count
75
Registration Number
NCT03250494

Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients

Completed
Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
Diagnostic Test: serum ferritin
First Posted Date
2017-08-15
Last Posted Date
2017-08-15
Lead Sponsor
Ain Shams University
Target Recruit Count
113
Registration Number
NCT03250572

Clinical Evaluation of Bio-creative Therapy for En Masse Retraction of the Maxillary Anterior Teeth

Not Applicable
Completed
Conditions
Malocclusion, Angle Class II, Division 1
Interventions
Procedure: Biocreative therapy
First Posted Date
2017-08-04
Last Posted Date
2019-01-16
Lead Sponsor
Ain Shams University
Target Recruit Count
30
Registration Number
NCT03239275

Socket Augmentation Using Platelet Concentrates, Atorvastatin Gel or Combination

Phase 4
Completed
Conditions
Alveolar Socket Preservations
Interventions
Drug: ATV gel
Biological: PRF
Biological: PRGF
Combination Product: PRGF/ATV
First Posted Date
2017-07-27
Last Posted Date
2017-07-27
Lead Sponsor
Ain Shams University
Target Recruit Count
50
Registration Number
NCT03231137
© Copyright 2025. All Rights Reserved by MedPath